Found 8 matching trials
Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
N/AA surveillance of respiratory tract related adverse events in patients trea...
Location
Cardiovascular Associates, P.C.
Study of Remodulin® in Pediatric Pulmonary Hypertension With Single Ventricular Physiology After Fontan Surgery
PHASE3The aim of this study is to determine the safety and efficiency of Remoduli...
Location
Multiple Locations
Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH
PHASE2This is a multicenter, single-arm trial to evaluate the safety of the trans...
Location
Multiple Locations
Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
PHASE4The purpose of this study is to assess tolerability and clinical effects of...
Location
University of Arizona
Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
PHASE3The purpose of this study is to assess and compare the safety of continuous...
Location
University of South Florida College of Medicine
DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study
NAThe purpose of the DelIVery for PAH clinical study is to evaluate the safet...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft
PHASE2Approximately 30 patients will be enrolled in this 12-week study designed t...
Location
Southern Illinois University School of Medicine
Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
PHASE3The purpose of this study is to determine if there is a greater effect to p...
Location
University of Arizona